" class="no-js "lang="en-US"> Fundraising Archives - Page 2 of 37 - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Protai Adds $12 Million to Seed Round to Build an Oncology Drug Discovery Pipeline

Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, […]

Myosin Therapeutics Closes Seed Round to Continue Development of Innovative Therapies for Glioblastoma and Stimulant Use Disorder

Myosin Therapeutics, a biotechnology company leveraging its innovative platform technology to identify new molecular entities […]

Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies

Mediar Therapeutics, a biotechnology company advancing a portfolio of first-in-class therapies that halt and even […]

Teitur Trophics Raises €28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

Teitur Trophics, a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative […]

Ambrx Raises $78 Million and Completes its ATM Program

Ambrx Biopharma today announced that it has completed net sales of approximately $78 million of […]

Allorion Therapeutics Raises $50 Million Series B Financing

Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, […]

Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round led by Forbion and Jeito Capital

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that […]

Prana Thoracic Announces Series A Financing

Prana Thoracic, a medical device company developing the first minimally invasive lung tissue excision tool […]

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology

Chroma Medicine, a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the completion […]

Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform

Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]

  1. Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
  2. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  3. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  4. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  5. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more